Amgen Inc.

NASDAQ: AMGN · Real-Time Price · USD
296.52
6.23 (2.15%)
At close: Aug 15, 2025, 3:59 PM
295.96
-0.19%
After-hours: Aug 15, 2025, 05:03 PM EDT

Amgen Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
6.62B 5.93B 4.09B 4.23B 3.13B 3.76B 6.72B 7.57B 7.98B 7.92B 6.55B 6.83B 6.58B 5.72B 5.89B 5.61B 5.75B 7.08B
Depreciation & Amortization
5.52B 5.58B 5.59B 5.58B 5.07B 4.57B 4.07B 3.6B 3.54B 3.48B 3.42B 3.36B 3.37B 3.4B 3.4B 3.42B 3.47B 3.54B
Stock-Based Compensation
512M 512M 530M 869M 837M 799M 743M 671M 567M 448M 401M 341M 341M 341M 341M 330M 330M 330M
Other Working Capital
75M -1.49B -3B -3.57B -3.63B -1.27B 442M 1.57B 1.94B 366M 601M 562M 155M -288M -531M -975M -1.8B -408M
Other Non-Cash Items
-379M 1.28B 2.22B -1B 674M 1.01B -1.3B -974M -1.38B -1.18B 1.28B 1.1B 1.09B 1.74B 1.28B 1.23B 1.24B -223M
Deferred Income Tax
-1.12B -1.08B -1.23B -1.52B -1.85B -1.63B -1.27B -1B -887M -996M -1.2B -1.04B -830M -613M -453M -212M -163M -294M
Change in Working Capital
856M -38M 286M -898M -1.42B -422M -484M 718M 975M -1.04B -733M -716M -1.23B -1.27B -1.19B -1.77B -1.06B 24M
Operating Cash Flow
12.01B 12.19B 11.49B 7.26B 6.45B 8.1B 8.47B 10.58B 10.8B 8.62B 9.72B 9.88B 9.32B 9.32B 9.26B 8.61B 9.56B 10.47B
Capital Expenditures
-1.41B -1.28B -1.1B -974M -965M -998M -1.11B -1.2B -1.11B -1.09B -936M -883M -965M -904M -880M -766M -659M -632M
Cash Acquisitions
n/a n/a n/a -26.99B -26.99B -26.99B -26.99B -3.73B -3.73B -3.73B -3.73B -893M -1.06B -2.69B -2.69B -1.86B -2.2B -574M
Purchase of Investments
n/a n/a n/a 26.99B 26.99B 26.99B 26.99B -225M -611M -2.59B -2.59B -2.36B -2.88B -1.3B -8.9B -12.05B -14.25B -15.95B
Sales Maturities Of Investments
n/a n/a n/a -2M -2M -1M 1.67B 2.45B 2.85B 2.86B 1.22B 1.35B 2.35B 5.74B 13.23B 14.37B 15.07B 11.81B
Other Investing Acitivies
-40M 1M 50M -26.76B -26.82B -26.78B -26.76B 121M 14M -31M -12M -14M 88M 91M -35M -121M -89M -153M
Investing Cash Flow
-1.45B -1.28B -1.05B -27.73B -27.79B -27.78B -26.2B -2.59B -2.59B -4.58B -6.04B -2.8B -2.46B 941M 733M -421M -2.12B -5.49B
Debt Repayment
-2.2B -3.6B -4.01B -14M 1.44B 2.82B 26.32B 22.61B 26.34B 26.36B 7.22B 2.79B 4.75B 4.75B 795M 3.5B -1.54B 751M
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -6.36B -7.8B -8.88B -10.46B -4.97B -4.74B -4.42B -3.4B
Dividend Paid
-4.97B -4.9B -4.83B -4.77B -4.7B -4.63B -4.56B -4.46B -4.35B -4.25B -4.2B -4.15B -4.11B -4.08B -4.01B -3.96B -3.89B -3.83B
Other Financial Acitivies
-4.66B -3.31B -573M -473M -348M -361M -719M -904M -1.15B -1.12B -697M -384M -45M -52M -78M -107M -97M -81M
Financial Cash Flow
-11.84B -11.81B -9.41B -5.25B -3.61B -2.17B 21.05B 17.25B 20.84B 20.99B -4.04B -9.55B -8.29B -9.85B -8.27B -5.3B -9.95B -6.55B
Net Cash Flow
-1.27B -898M 1.03B -25.73B -24.95B -21.85B 3.31B 25.24B 29.05B 25.03B -360M -2.47B -1.43B 416M 1.72B 2.88B -2.52B -1.57B
Free Cash Flow
10.61B 10.91B 10.39B 6.28B 5.48B 7.1B 7.36B 9.38B 9.69B 7.53B 8.79B 9B 8.36B 8.42B 8.38B 7.84B 8.9B 9.84B